Literature DB >> 26959846

Polymer-coated pH-responsive high-density lipoproteins.

Hyungjin Kim1, Haruki Okamoto1, Arnaud E Felber2, Anna Polomska2, Nobuhiro Morone1, John E Heuser1, Jean-Christophe Leroux2, Tatsuya Murakami3.   

Abstract

Intracellular drug delivery by nanoparticles is often hampered by their endosomal entrapment followed by their degradation in the lysosomal compartment and/or exocytosis. Here, we show that internalization and endosomal escape of cargoes in a cationized natural nanocarrier, high-density lipoprotein (HDL), can be controlled in a pH-dependent manner through stable complexation with a membranolytic anionic block polymer. A genetically and chemically cationized form of HDL (catHDL) is prepared for the first time by both genetic fusion with YGRKKRRQRRR peptide and incorporation of 1,2-dioleoyloxy-3-(trimethylammonium)propane. Upon addition of poly(ethylene glycol)-block-poly(propyl methacrylate-co-methacrylic acid) (PA), catHDL yields inhibition of internalization at neutral pH and its subsequent recovery at mildly acidic pH. catHDL forms a stable discoidal-shape complex with PA (catHDL/PA) (ca. 50 nm in diameter), even in the presence of serum. Significant enhancement of endosomal escape of a catHDL component is observed after a 1-h treatment of human cancer cells with catHDL/PA. Doxorubicin and curcumin, fluorescent anti-cancer drugs, encapsulated into catHDL/PA are also translocated outside of endosomes, compared with that into catHDL, and their cytotoxicities are enhanced inside the cells. These data suggest that catHDL/PA may have a potential benefit to improve the cellular delivery and endosomal escape of therapeutics under mildly acidic conditions such as in tumor tissues.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anticancer drug delivery; Endosomal escape; Internalization; Membranolytic polymer; Mildly acidic pH

Mesh:

Substances:

Year:  2016        PMID: 26959846     DOI: 10.1016/j.jconrel.2016.03.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  3 in total

Review 1.  Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.

Authors:  Xianglei Fu; Yanbin Shi; Tongtong Qi; Shengnan Qiu; Yi Huang; Xiaogang Zhao; Qifeng Sun; Guimei Lin
Journal:  Signal Transduct Target Ther       Date:  2020-11-06

Review 2.  Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery.

Authors:  Xinyi Ma; Qingxiang Song; Xiaoling Gao
Journal:  Acta Pharm Sin B       Date:  2017-12-24       Impact factor: 11.413

3.  Multifunctionalized polyethyleneimine-based nanocarriers for gene and chemotherapeutic drug combination therapy through one-step assembly strategy.

Authors:  Dandan Jiang; Mingfang Wang; Tianqi Wang; Bo Zhang; Chunxi Liu; Na Zhang
Journal:  Int J Nanomedicine       Date:  2017-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.